These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 31994191)

  • 1. Exosome-mediated transfer of long noncoding RNA H19 induces doxorubicin resistance in breast cancer.
    Wang X; Pei X; Guo G; Qian X; Dou D; Zhang Z; Xu X; Duan X
    J Cell Physiol; 2020 Oct; 235(10):6896-6904. PubMed ID: 31994191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA H19 regulates proliferation and doxorubicin resistance in MCF-7 cells by targeting PARP1.
    Wang Y; Zhou P; Li P; Yang F; Gao XQ
    Bioengineered; 2020 Dec; 11(1):536-546. PubMed ID: 32345117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomes from adriamycin-resistant breast cancer cells transmit drug resistance partly by delivering miR-222.
    Yu DD; Wu Y; Zhang XH; Lv MM; Chen WX; Chen X; Yang SJ; Shen H; Zhong SL; Tang JH; Zhao JH
    Tumour Biol; 2016 Mar; 37(3):3227-35. PubMed ID: 26432333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor‑released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non‑small cell lung cancer.
    Lei Y; Guo W; Chen B; Chen L; Gong J; Li W
    Oncol Rep; 2018 Dec; 40(6):3438-3446. PubMed ID: 30542738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes regulate doxorubicin resistance in breast cancer via miR-34a-5p/NOTCH1.
    Chen NN; Zhou KF; Miao Z; Chen YX; Cui JX; Su SW
    Mol Cell Probes; 2024 Aug; 76():101964. PubMed ID: 38810840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosome-mediated transfer of lncRNA‑SNHG14 promotes trastuzumab chemoresistance in breast cancer.
    Dong H; Wang W; Chen R; Zhang Y; Zou K; Ye M; He X; Zhang F; Han J
    Int J Oncol; 2018 Sep; 53(3):1013-1026. PubMed ID: 30015837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC00160 mediated paclitaxel-And doxorubicin-resistance in breast cancer cells by regulating TFF3 via transcription factor C/EBPβ.
    Wu H; Gu J; Zhou D; Cheng W; Wang Y; Wang Q; Wang X
    J Cell Mol Med; 2020 Aug; 24(15):8589-8602. PubMed ID: 32652877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy.
    Wang J; Xie S; Yang J; Xiong H; Jia Y; Zhou Y; Chen Y; Ying X; Chen C; Ye C; Wang L; Zhou J
    J Hematol Oncol; 2019 Jul; 12(1):81. PubMed ID: 31340867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK.
    Si X; Zang R; Zhang E; Liu Y; Shi X; Zhang E; Shao L; Li A; Yang N; Han X; Pan B; Zhang Z; Sun L; Sun Y
    Oncotarget; 2016 Dec; 7(49):81452-81462. PubMed ID: 27845892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Elemene Reverses Chemoresistance of Breast Cancer Cells by Reducing Resistance Transmission via Exosomes.
    Zhang J; Zhang HD; Yao YF; Zhong SL; Zhao JH; Tang JH
    Cell Physiol Biochem; 2015; 36(6):2274-86. PubMed ID: 26279432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long Non-coding RNA H19 Recruits NFYB to Activate MBTD1 and Regulate Doxorubicin Resistance in Lymphoma Cells.
    Feng L; Yan Q; Xu X
    Mol Biotechnol; 2023 Jun; 65(6):997-1009. PubMed ID: 36434485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between long non-coding RNAs (lncRNAs) H19 expression and trastuzumab resistance in breast cancer.
    Sun Z; Zhang C; Wang T; Shi P; Tian X; Guo Y
    J Cancer Res Ther; 2019; 15(4):933-940. PubMed ID: 31436255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin resistance in breast cancer xenografts and cell lines can be counterweighted by microRNA-140-3p, through PD-L1 suppression.
    Zhang X; Wang C; Huang C; Yang J; Wang J
    Histol Histopathol; 2023 Oct; 38(10):1193-1204. PubMed ID: 36621840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells.
    Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL
    Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Expression of Exosomal AGAP2-AS1 (AGAP2 Antisense RNA 1) In Breast Cancer Cells Inhibits Trastuzumab-Induced Cell Cytotoxicity.
    Zheng Z; Chen M; Xing P; Yan X; Xie B
    Med Sci Monit; 2019 Mar; 25():2211-2220. PubMed ID: 30910994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldo-keto reductase 1C3 (AKR1C3) is associated with the doxorubicin resistance in human breast cancer via PTEN loss.
    Zhong T; Xu F; Xu J; Liu L; Chen Y
    Biomed Pharmacother; 2015 Feb; 69():317-25. PubMed ID: 25661377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA H19 is a major mediator of doxorubicin chemoresistance in breast cancer cells through a cullin4A-MDR1 pathway.
    Zhu QN; Wang G; Guo Y; Peng Y; Zhang R; Deng JL; Li ZX; Zhu YS
    Oncotarget; 2017 Nov; 8(54):91990-92003. PubMed ID: 29190892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular iodine impairs chemoresistance mechanisms, enhances doxorubicin retention and induces downregulation of the CD44+/CD24+ and E-cadherin+/vimentin+ subpopulations in MCF-7 cells resistant to low doses of doxorubicin.
    Bontempo A; Ugalde-Villanueva B; Delgado-González E; Rodríguez ÁL; Aceves C
    Oncol Rep; 2017 Nov; 38(5):2867-2876. PubMed ID: 28901484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of RSK4 reverses doxorubicin resistance in human breast cancer cells via PI3K/AKT signalling pathway.
    Mei Y; Liao X; Zhu L; Yang H
    J Biochem; 2020 Jun; 167(6):603-611. PubMed ID: 31960922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs.
    Chen WX; Liu XM; Lv MM; Chen L; Zhao JH; Zhong SL; Ji MH; Hu Q; Luo Z; Wu JZ; Tang JH
    PLoS One; 2014; 9(4):e95240. PubMed ID: 24740415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.